8-KEarnings & ResultsLeadership ChangesExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Jul 30, 2025)

Filed July 30, 2025For Securities:DXCM

Summary

DexCom, Inc. (DXCM) has filed an 8-K report detailing its financial results for the quarter ended June 30, 2025, and announcing significant leadership transitions. While specific financial figures are not provided in this extract, the company has confirmed the release of its quarterly earnings through a press release furnished as Exhibit 99.1. Investors should refer to this press release for detailed performance metrics and operational highlights for the period. The most substantial news in this filing pertains to executive leadership. CEO Kevin R. Sayer will retire from his CEO role effective January 1, 2026, transitioning to Executive Chairman. Concurrently, current President and COO, Jacob S. Leach, will assume the CEO position on January 1, 2026. Mr. Leach will also join the Board of Directors as part of these changes. The company stated that no new compensatory arrangements have been finalized for these roles as of the filing date.

Key Highlights

  • 1DexCom announced financial results for the quarter ended June 30, 2025, via a press release furnished with the filing.
  • 2Current CEO Kevin R. Sayer to retire as CEO effective January 1, 2026.
  • 3Kevin R. Sayer will transition to Executive Chairman of the Board, effective January 1, 2026.
  • 4Jacob S. Leach, currently President and COO, appointed as the new President and CEO, effective January 1, 2026.
  • 5Jacob S. Leach will also be appointed to the Board of Directors effective January 1, 2026.
  • 6No new material compensatory plans, contracts, or awards related to these leadership changes have been entered into as of the filing date.
  • 7The Board of Directors will be increased to ten members effective January 1, 2026.

Frequently Asked Questions

The leadership changes, including Kevin R. Sayer's transition to Executive Chairman and Jacob S. Leach's appointment as CEO, will become effective on January 1, 2026.

This 8-K filing announces that DexCom released its financial results for the quarter ended June 30, 2025, via a press release (Exhibit 99.1). Specific financial details are not included in this extract, and investors should refer to the furnished press release for that information.

As of the filing date, DexCom has not entered into any new material plans, contracts, or arrangements, nor made any amendments or awards in connection with Mr. Leach's appointment as CEO. His previously reported compensation remains in effect.

Upon his retirement as CEO, Kevin R. Sayer will assume the role of Executive Chairman of the Board, effective January 1, 2026, to continue providing leadership and strategic guidance to the Company.